MESO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mesoblast Ltd (MESO) is not a strong buy at this moment for a beginner investor with a long-term focus. While the company has shown impressive revenue growth driven by the launch of Ryoncil®, the technical indicators and options data suggest a neutral to slightly bearish sentiment in the short term. Additionally, the lack of recent trading signals and the absence of significant positive catalysts make it prudent to hold off on immediate investment.
The MACD histogram is negative (-0.16) and contracting, indicating bearish momentum. RSI is neutral at 47.727, and moving averages are converging, showing no clear trend. Key support and resistance levels are at S1: 14.085 and R1: 16.988, with the stock currently trading near the pivot point of 15.536.
The company reported a 1503.1% year-over-year revenue increase to $51.3 million for H1 FY2026, driven by the successful launch of Ryoncil®, which generated significant gross sales and profit.
The stock has a 90% chance of declining by -4.1% in the next day and -1.89% in the next week based on candlestick pattern analysis. Additionally, the GAAP EPS of -$3.11 missed expectations, reflecting ongoing profitability challenges.
Mesoblast reported a 1503.1% year-over-year revenue increase to $51.3 million for H1 FY2026. This growth was driven by the successful launch of Ryoncil®. However, the company posted a GAAP EPS of -$3.11, missing expectations, which raises concerns about profitability.
No recent updates on analyst ratings or price target changes. Wall Street sentiment appears neutral with no significant pros or cons highlighted.
